Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02009722 · ClinicalTrials.gov registry record · Phase 4
Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
A Phase 4 study of Cesarean Section and Analgesia, Obstetrical, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT02009722 is a Phase 4 study of Cesarean Section and Analgesia, Obstetrical that has completed, run by Mayo Clinic. The registered enrollment target is 84 participants, below the 164-participant average among 14 other Cesarean Section trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02009722, a Phase 4 study of Cesarean Section and Analgesia, Obstetrical, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Both hydromorphone and morphine are administered as part of spinal anesthesia to help improve pain control after cesarean delivery. In this study, the investigators are going to determine the doses of each of those medicines that provides optimal pain control to women undergoing cesarean delivery while limiting side effects related to those medicines. The investigators hypothesize that the doses of hydromorphone and morphine that provide optimal pain control without significant side effects will be 100 micrograms and 150 micrograms, respectively. The investigators further hypothesize that at each respective optimal dose, side effects will be less in the hydromorphone group.
Conditions Studied
Interventions
- DRUG Hydromorphone
- DRUG Morphine
Study Locations (1)
Minnesota
- Rochester Methodist Hospital, Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02009722
The ClinicalTrials.gov registry entry for NCT02009722 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 14 other Cesarean Section trials with a reported enrollment target (49% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Hydromorphone is the first listed.
NCT02009722 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02009722 about?
NCT02009722 is a clinical study titled "Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose". Both hydromorphone and morphine are administered as part of spinal anesthesia to help improve pain control after cesarean delivery. In this study, the investigators are going to determine the doses of each of those medicines that provides optimal pain control to women undergoing cesarean delivery wh...
What is the current status of trial NCT02009722?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2014-01. Estimated completion is 2015-04.
What conditions does trial NCT02009722 study?
This clinical trial studies the following conditions: Cesarean Section, Analgesia, Obstetrical.
What interventions are being tested in trial NCT02009722?
The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02009722?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02009722 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intrathecal Dexmedetomidine vs Epinephrine
RECRUITING · Phase 4
-
Seprafilm® Adhesion Barrier and Cesarean Delivery
COMPLETED · Phase 4
-
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
COMPLETED · Phase 4
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
-
Post-operative Cesarean Trial of Pain Control
RECRUITING · NA
-
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.